BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 21410396)

  • 1. The role of natural killer cells in hematopoietic stem cell transplantation.
    Tsirigotis PD; Resnick IB; Shapira MY
    Ann Med; 2012 Mar; 44(2):130-45. PubMed ID: 21410396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells--new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation.
    Patil S; Schwarer T
    Intern Med J; 2009 Oct; 39(10):639-47. PubMed ID: 19686544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of natural killer cells in hematopoietic stem cell transplantation: myth or reality?
    Nguyen S; Béziat V; Roos-Weil D; Vieillard V
    J Innate Immun; 2011; 3(4):383-94. PubMed ID: 21411973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human NK receptors: from the molecules to the therapy of high risk leukemias.
    Moretta L; Locatelli F; Pende D; Sivori S; Falco M; Bottino C; Mingari MC; Moretta A
    FEBS Lett; 2011 Jun; 585(11):1563-7. PubMed ID: 21554879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell alloreactivity 10 years later.
    Velardi A
    Curr Opin Hematol; 2012 Nov; 19(6):421-6. PubMed ID: 22954728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells as a therapeutic tool in mismatched transplantation.
    Ruggeri L; Capanni M; Mancusi A; Aversa F; Martelli MF; Velardi A
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):427-38. PubMed ID: 15498714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell tolerance licensing and other mechanisms.
    Jonsson AH; Yokoyama WM
    Adv Immunol; 2009; 101():27-79. PubMed ID: 19231592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H; Qian X
    Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells in the treatment of high-risk acute leukaemia.
    Locatelli F; Moretta F; Brescia L; Merli P
    Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
    Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
    Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
    Moretta A; Locatelli F; Moretta L
    Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of methods required to evaluate donor NK cell alloreactivity for haploidentical haemopoietic stem cell transplantation.
    Velardi A
    Methods Mol Biol; 2012; 882():469-76. PubMed ID: 22665250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation.
    Nguyen S; Béziat V; Norol F; Uzunov M; Trebeden-Negre H; Azar N; Boudifa A; Bories D; Debré P; Vernant JP; Vieillard V; Dhédin N
    Transfusion; 2011 Aug; 51(8):1769-78. PubMed ID: 21332732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactive natural killer cells in targeting high-risk leukaemias.
    Moretta L; Locatelli F; Moretta A
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii39-43. PubMed ID: 19022812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
    Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
    Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT.
    Giebel S; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Nowak I; Holowiecka A; Segatti A; Kyrcz-Krzemien S; Kusnierczyk P; Holowiecki J
    Bone Marrow Transplant; 2010 Jun; 45(6):1022-30. PubMed ID: 20118994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Capanni M; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2008; 40(1):84-90. PubMed ID: 17964828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.
    Passweg JR; Koehl U; Uharek L; Meyer-Monard S; Tichelli A
    Best Pract Res Clin Haematol; 2006; 19(4):811-24. PubMed ID: 16997185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia.
    Velardi A; Ruggeri L; Mancusi A; Aversa F; Christiansen FT
    Curr Opin Immunol; 2009 Oct; 21(5):525-30. PubMed ID: 19717293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.
    Ruggeri L; Capanni M; Mancusi A; Urbani E; Perruccio K; Burchielli E; Tosti A; Topini F; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2004; 33(3):216-21. PubMed ID: 15528134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.